ArriVent BioPharma, Inc. - Common Stock (AVBP)

CUSIP: 04272N102

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+4,887,041
Put/Call ratio
321%
SEC-reported price per share
$18.45
Number of holders
104
Value change
+$89,390,684
Number of buys
60
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
46,795,294

Security key

04272N102

Report period

Q3 2025

Institutions

104

Top holders

10

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
11 Aug 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: SUVRETTA CAPITAL MANAGEMENT, LLC Showing 1-6 of 15 holder rows.

Quick read

SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SUVRETTA CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC 9.9%
ORBIMED ADVISORS LLC 7.5%
Octagon Capital Advisors LP 4.9%
Novo Holdings A/S 4.9%
HHLR ADVISORS, LTD. 9.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 13F
Company
9.9%
$75,183,720
3,412,788 shares
$0 30 Jun 2025
ORBIMED ADVISORS LLC
13D/G 3/4/5 13F
Director, 10%+ Owner · Company
7.5%
$66,692,036
3,027,328 shares
$0 11 Aug 2025
Octagon Capital Advisors LP
13F 13D/G
Company
4.9%
from 13D/G
$42,365,596
1,946,054 shares
30 Jun 2025
Novo Holdings A/S
13F 13D/G
Company
4.9%
from 13D/G
$40,756,531
1,872,142 shares
30 Jun 2025
HHLR ADVISORS, LTD.
13F
Company
13F
9.6%
$97,631,309
4,484,672 shares
30 Jun 2025
INFINITUM ASSET MANAGEMENT, LLC
13F
Company
13F
7.3%
$74,429,954
3,418,923 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
104
Shares
38,570,342
Rows available
104
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
96
Q3 2025 holders
104
Holder diff
8
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .